🇰🇷 South Korea Country × Condition
bkv infection Clinical Trials in South Korea
Active clinical trials for bkv infection with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇰🇷 South Korea
Active Trials in South Korea (2)
NCT07685457
Recruiting
Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation.
Enrollment
6 pts
Country
🇰🇷 South Korea
LucasBio
View Trial → NCT07670468 Phase 1, Phase 2
Recruiting
Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.
Enrollment
27 pts
Country
🇰🇷 South Korea
LucasBio
View Trial → Frequently Asked Questions
How many bkv infection clinical trials are active in South Korea?
There are currently 2 active clinical trials for bkv infection with sites in South Korea, of which 2 are actively recruiting patients.
How can I join a bkv infection clinical trial in South Korea?
To join a bkv infection clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are bkv infection trials in South Korea?
Active bkv infection trials in South Korea span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology